Search Within

Hugo Castro-Malaspina

Formats
  1. Meeting Abstract (212)
  2. Journal Article (111)
  3. Conference Paper (8)
  4. Research Letter (2)
Groups
  1. Bone Marrow Transplant (333)
  2. Center for Hematologic Malignancies (333)
  3. Department of Medicine (333)
  4. Hematologic Malignancies, Division of (333)
  5. Sloan Kettering Institute Faculty (212)
  6. Pediatrics, Department of (210)

More Groups

People
  1. Esperanza Papadopoulos (211)
  2. Miguel-Angel Perales (187)
  3. Ann Jakubowski (185)
  4. Richard O'Reilly (184)
  5. Sergio Giralt (164)
  6. James Young (157)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (4)
  4. 2020 (8)
  5. 2019 (13)
  6. 2018 (23)

More Years

Publications
  1. Blood (134)
  2. Biology of Blood and Marrow Transplantation (97)
  3. Bone Marrow Transplantation (34)
  4. Experimental Hematology (9)
  5. British Journal of Haematology (6)
  6. Journal of Clinical Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (136)
  2. Elsevier Inc. (106)
  3. Nature Publishing Group (35)
  4. Elsevier Science, Inc. (11)
  5. John Wiley & Sons (8)
  6. American Society of Clinical Oncology (5)

More Publishers

Results (333)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Devlin, S.; Maloy, M.; Kosuri, S.; Herrera, D. A.; Nieves, J.; Avecilla, S. T.; Meagher, R. C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Myeloablative conditioning and CD34+ selection results in higher chronic-GVHD free/relapse free-survival compared to reduced-intensity conditioning and unmodified graft in patients with AML and MDS > 50 years receiving HLA-matched allogeneic HCT
    Meeting Abstract

    Barba, P.; Martino, R.; Zhou, Q.; Cho, C.; Castro-Malaspina, H.; Devlin, S.; Esquirol, A.; Giralt, S.; Jakubowski, A.; Lopez-Corral, L.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Long-term prognosis of one-year survivors of CD34-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis
    Meeting Abstract

    Cho, C.; Hsu, M.; Avecilla, S.; Barba, P.; Barker, J.; Castro-Malaspina, H.; Devlin, S.; Giralt, S.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with advanced myelodysplastic syndrome undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Proli, A. J.; Tamari, R.; Zheng, J.; Jakubowski, A. A.; Papadopoulos, E.; Ponce, D. M.; Devlin, S. M.; Sauter, C. S.; Perales, M. A.; Young, J. W.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells (HPC) does not improve neutrophil recovery or survival in patients undergoing allogeneic
    Meeting Abstract

    Kosuri, S.; Gyurkocza, B.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Borrill, T.; Jakubowski, A. A.; Papadopoulos, E.; Castro-Malaspina, H.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save